211 related articles for article (PubMed ID: 31451335)
1. Comparing oncologic outcomes in patients undergoing surgery for oncocytic neoplasms, conventional oncocytoma, and chromophobe renal cell carcinoma.
Flack CK; Calaway AC; Miller BL; Picken MM; Gondim DD; Idrees MT; Abel EJ; Gupta GN; Boris RS
Urol Oncol; 2019 Nov; 37(11):811.e17-811.e21. PubMed ID: 31451335
[TBL] [Abstract][Full Text] [Related]
2. Editorial comment on: hybrid renal cell carcinomas containing histopathologic features of chromophobe renal cell carcinoma and oncocytoma have excellent oncologic outcomes.
Becker F
Eur Urol; 2010 Apr; 57(4):666. PubMed ID: 19477584
[No Abstract] [Full Text] [Related]
3. Characteristics of the Peritumoral Pseudocapsule Vary Predictably With Histologic Subtype of T1 Renal Neoplasms.
Jacob JM; Williamson SR; Gondim DD; Leese JA; Terry C; Grignon DJ; Boris RS
Urology; 2015 Nov; 86(5):956-61. PubMed ID: 26126697
[TBL] [Abstract][Full Text] [Related]
4. Active Surveillance for Renal Neoplasms with Oncocytic Features is Safe.
Richard PO; Jewett MA; Bhatt JR; Evans AJ; Timilsina N; Finelli A
J Urol; 2016 Mar; 195(3):581-6. PubMed ID: 26388501
[TBL] [Abstract][Full Text] [Related]
5. Renal oncocytoma: a clinicopathologic study of 70 cases.
Perez-Ordonez B; Hamed G; Campbell S; Erlandson RA; Russo P; Gaudin PB; Reuter VE
Am J Surg Pathol; 1997 Aug; 21(8):871-83. PubMed ID: 9255250
[TBL] [Abstract][Full Text] [Related]
6. Hybrid renal cell carcinomas containing histopathologic features of chromophobe renal cell carcinomas and oncocytomas have excellent oncologic outcomes.
Waldert M; Klatte T; Haitel A; Ozsoy M; Schmidbauer J; Marberger M; Remzi M
Eur Urol; 2010 Apr; 57(4):661-5. PubMed ID: 19477583
[TBL] [Abstract][Full Text] [Related]
7. Surgical histopathology for suspected oncocytoma on renal mass biopsy: a systematic review and meta-analysis.
Patel HD; Druskin SC; Rowe SP; Pierorazio PM; Gorin MA; Allaf ME
BJU Int; 2017 May; 119(5):661-666. PubMed ID: 28058773
[TBL] [Abstract][Full Text] [Related]
8. Identification and Validation of Radiographic Enhancement for Reliable Differentiation of CD117(+) Benign Renal Oncocytoma and Chromophobe Renal Cell Carcinoma.
Amin J; Xu B; Badkhshan S; Creighton TT; Abbotoy D; Murekeyisoni C; Attwood KM; Schwaab T; Hendler C; Petroziello M; Roche CL; Kauffman EC
Clin Cancer Res; 2018 Aug; 24(16):3898-3907. PubMed ID: 29752278
[No Abstract] [Full Text] [Related]
9. Sporadic oncocytic tumors with features intermediate between oncocytoma and chromophobe renal cell carcinoma: comprehensive clinicopathological and genomic profiling.
Liu YJ; Ussakli C; Antic T; Liu Y; Wu Y; True L; Tretiakova MS
Hum Pathol; 2020 Oct; 104():18-29. PubMed ID: 32673684
[TBL] [Abstract][Full Text] [Related]
10. Low-Grade Oncocytic Tumor of Kidney (CK7-Positive, CD117-Negative): Incidence in a single institutional experience with clinicopathological and molecular characteristics.
Kravtsov O; Gupta S; Cheville JC; Sukov WR; Rowsey R; Herrera-Hernandez LP; Lohse CM; Knudson R; Leibovich BC; Jimenez RE
Hum Pathol; 2021 Aug; 114():9-18. PubMed ID: 33961838
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic utility of S100A1, GLUT-1 and Caveolin-1 in renal tumors with oncocytic features: a comparative study].
Zhang W; Wang K; Yu W; Liu Y; Chu J; Jiang Y; Li Y
Zhonghua Bing Li Xue Za Zhi; 2015 Nov; 44(11):767-71. PubMed ID: 26888385
[TBL] [Abstract][Full Text] [Related]
12. Comparative Analysis of Surgery, Thermal Ablation, and Active Surveillance for Renal Oncocytic Neoplasms.
Miller BL; Mankowski Gettle L; Van Roo JR; Ziemlewicz TJ; Best SL; Wells SA; Lubner MG; Hinshaw JL; Lee FT; Nakada SY; Huang W; Abel EJ
Urology; 2018 Feb; 112():92-97. PubMed ID: 29030073
[TBL] [Abstract][Full Text] [Related]
13. Editorial comment on: hybrid renal cell carcinomas containing histopathologic features of chromophobe renal cell carcinomas and oncocytomas have excellent oncologic outcomes.
Bex A
Eur Urol; 2010 Apr; 57(4):665. PubMed ID: 19477585
[No Abstract] [Full Text] [Related]
14. Validation of aorta-lesion-attenuation difference on preoperative contrast-enhanced computed tomography scan to differentiate between malignant and benign oncocytic renal tumors.
Grajo JR; Batra NV; Bozorgmehri S; Magnelli LL; Pavlinec J; O'Malley P; Su LM; Crispen PL
Abdom Radiol (NY); 2021 Jul; 46(7):3269-3279. PubMed ID: 33665734
[TBL] [Abstract][Full Text] [Related]
15. Cytomorphology, immunoprofile, and management of renal oncocytic neoplasms.
Zhu B; Rohan SM; Lin X
Cancer Cytopathol; 2020 Dec; 128(12):962-970. PubMed ID: 32697415
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic criteria for oncocytic renal neoplasms: a survey of urologic pathologists.
Williamson SR; Gadde R; Trpkov K; Hirsch MS; Srigley JR; Reuter VE; Cheng L; Kunju LP; Barod R; Rogers CG; Delahunt B; Hes O; Eble JN; Zhou M; McKenney JK; Martignoni G; Fleming S; Grignon DJ; Moch H; Gupta NS
Hum Pathol; 2017 May; 63():149-156. PubMed ID: 28315424
[TBL] [Abstract][Full Text] [Related]
17. Rare Case of Hybrid Oncocytoma and Chromophobe Renal Cell Carcinoma in a Pediatric Patient.
Gibson A; Ray A
Pediatr Blood Cancer; 2016 Jun; 63(6):1127. PubMed ID: 26718018
[No Abstract] [Full Text] [Related]
18. Low grade oncocytic renal tumor (LOT): Clinicopathological characterization of 13 cases.
Almutairi F; Xu B
Pathol Res Pract; 2024 Feb; 254():155127. PubMed ID: 38241777
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of KAI1 metastasis suppressor protein in renal cell tumor histological subtypes.
Kauffman EC; Barocas DA; Chen YT; Yang XJ; Scherr DS; Tu JJ
J Urol; 2009 May; 181(5):2305-11. PubMed ID: 19303095
[TBL] [Abstract][Full Text] [Related]
20. A collision tumor of papillary renal cell carcinoma and oncocytoma: case report and literature review.
Goyal R; Parwani AV; Gellert L; Hameed O; Giannico GA
Am J Clin Pathol; 2015 Nov; 144(5):811-6. PubMed ID: 26486747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
